Application 019627
- Type
- NDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DIPRIVAN | PROPOFOL | INJECTABLE;INJECTION | 10MG/ML | No | No |
| 002 | DIPRIVAN | PROPOFOL | INJECTABLE;INJECTION | 10MG/ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019627-001 | DIPRIVAN | PROPOFOL | 10MG/ML | INJECTABLE / INJECTION | 1989-10-02 | ||
| N019627-002 | DIPRIVAN | PROPOFOL | 10MG/ML | INJECTABLE / INJECTION | AB | RLD, RS | 1996-06-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N019627-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N019627-001 | DIPRIVAN | 10MG/ML | INJECTABLE / INJECTION | 1989-10-02 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N019627-002 | DIPRIVAN | 10MG/ML | INJECTABLE / INJECTION | AB | RLD, RS | 1996-06-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N019627-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | e3105799-a4b6-f3f4-e6e2-b2b29bbdb538 | 2025-09-11 | Warnings, Adverse reactions | 019627 NDA019627 63323-269 |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | fee3bd4a-ade3-41fa-839a-48e9af69bcf4 | 2025-09-10 | Warnings, Adverse reactions | 019627 NDA019627 63323-269 |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | d1ae9e26-ffd6-43df-bbd6-869cdede6afe | 2025-04-21 | Warnings, Adverse reactions | 019627 NDA019627 63323-269 |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | ee0c3437-614d-4631-a061-257f5f60c70b | 2025-02-20 | Warnings, Adverse reactions | 019627 NDA019627 63323-269 |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | 5cec3b97-5183-4a9d-accd-21e76c99d3dd | 2024-04-18 | Warnings, Adverse reactions | 019627 NDA019627 65219-800 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 49836-024 | Anesthesia S/I-60 | Propofol, Sterile Isopropyl Alcohol | RX PHARMA-PACK, INC. | NDA | Current |
| 49836-024 | Anesthesia S/I-60 | Propofol, Sterile Isopropyl Alcohol | RX PHARMA-PACK, INC. | NDA | Current |
| 49836-024 | Anesthesia S/I-60 | Propofol, Sterile Isopropyl Alcohol | RX PHARMA-PACK, INC. | NDA | Current |
| 49836-025 | Anesthesia S/I-40 | Propofol, Isopropyl Alcohol | RX PHARMA-PACK, INC. | NDA | Current |
| 49836-025 | Anesthesia S/I-40 | Propofol, Isopropyl Alcohol | RX PHARMA-PACK, INC. | NDA | Current |
| 49836-025 | Anesthesia S/I-40 | Propofol, Isopropyl Alcohol | RX PHARMA-PACK, INC. | NDA | Current |
| 52584-269 | Diprivan | Diprivan | General Injectables & Vaccines, Inc | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-269 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 65219-800 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 65219-800 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
| 65219-800 | Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85080 | SUPPL | 2026-02-19 |
| 85079 | SUPPL | 2026-02-19 |
| 71993 | SUPPL | 2022-09-01 |
| 71986 | SUPPL | 2022-09-01 |
| 68284 | SUPPL | 2021-08-04 |
| 67461 | SUPPL | 2021-05-12 |
| 48220 | SUPPL | 2017-05-02 |
| 48192 | SUPPL | 2017-05-02 |
| 33816 | SUPPL | 2014-06-10 |
| 11571 | SUPPL | 2014-01-28 |
| 40941 | SUPPL | 2013-09-24 |
| 17492 | SUPPL | 2013-09-17 |
| 40940 | SUPPL | 2009-01-12 |
| 20269 | SUPPL | 2009-01-12 |
| 11570 | SUPPL | 2008-04-23 |
| 17491 | SUPPL | 2008-04-16 |
| 20268 | SUPPL | 2007-07-09 |
| 20267 | SUPPL | 2007-07-09 |
| 23549 | ORIG | 2007-06-18 |
| 11569 | SUPPL | 2007-02-21 |
| 17490 | SUPPL | 2007-02-12 |
| 11568 | SUPPL | 2001-02-23 |
| 1425 | SUPPL | 2001-02-23 |